Vanguard Personalized Indexing Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,280
| Closed | -$1.09M | – | 2054 |
|
|
2025
Q1 | $1.09M | Buy |
8,280
+1,242
| +18% | +$164K | 0.02% | 740 |
|
|
2024
Q4 | $588K | Sell |
7,038
-62
| -0.9% | -$5.18K | 0.01% | 1033 |
|
|
2024
Q3 | $520K | Buy |
7,100
+788
| +12% | +$57.7K | 0.01% | 1077 |
|
|
2024
Q2 | $432K | Buy |
6,312
+1,052
| +20% | +$72.1K | 0.01% | 1099 |
|
|
2024
Q1 | $364K | Sell |
5,260
-120
| -2% | -$8.3K | 0.01% | 1177 |
|
|
2023
Q4 | $385K | Buy |
5,380
+1,434
| +36% | +$103K | 0.01% | 1129 |
|
|
2023
Q3 | $206K | Buy |
3,946
+455
| +13% | +$23.7K | 0.01% | 1293 |
|
|
2023
Q2 | $221K | Buy |
+3,491
| New | +$221K | 0.01% | 1283 |
|